Application 202063
- Type
- ANDA
- Sponsor
- EMCURE PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 200MG BASE/VIAL | No | No |
| 002 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202063-001 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | ||
| A202063-002 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2012-09-11 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A202063-001 | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A202063-002 | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2012-09-11 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A202063-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202063-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A202063-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202063-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202063-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202063-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202063-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202063-002 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | c0b1b715-9ff8-43ca-9e49-465f1f380084 | 2025-07-23 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | NorthStar Rx LLC | 5af49a48-f1c0-467d-b5da-ac9f1ae8e34c | 2025-02-03 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | a5949d02-29eb-4626-ad35-b7614bb0fa95 | 2025-01-29 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| Gemcitabine hydrochloride | GEMCITABINE HYDROCHLORIDE | Teyro Labs Private Limited | a6ddaa2f-4c17-430f-a7cd-96b6662923f6 | 2025-01-09 | Warnings, Adverse reactions | Gemcitabine hydrochloride GEMCITABINE HYDROCHLORIDE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | 06dd9d40-74fc-4409-93b1-a46be7126331 | 2024-11-11 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| gemcitabine hydrochloride | GEMCITABINE HYDROCHLORIDE | Gland Pharma Limited | 9f8fe5ba-943f-4f0a-9618-6083101faa28 | 2024-09-06 | Warnings, Adverse reactions | gemcitabine hydrochloride GEMCITABINE HYDROCHLORIDE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | 2024-08-05 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 23155-213 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-213 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-214 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-214 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-483 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-484 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-528 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
| 23155-529 | Gemcitabine hydrochloride | Gemcitabine hydrochloride | Heritage Pharmaceuticals Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 43380 | ORIG | 2013-01-22 |